{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:02:03Z","timestamp":1794024123933,"version":"4.8.0"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"unspecified","delay-in-days":29,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2025,5,16]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the prevalence of symptoms associated with Charles-Bonnet syndrome (CBS) in adult patients with inherited retinal disease (IRD) and explore patient perspectives and need for support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This was a prospective single-centre cross-sectional service evaluation and improvement project that involved adult patients with a clinical diagnosis of IRD under the care of the specialist IRD service at a tertiary NHS healthcare provider in the UK. Information was gathered from a survey questionnaire completed by participants remotely or at a hospital appointment and electronic patient records.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 103 surveys returned of which 94 were suitable for inclusion in the analysis. Visual hallucinations were reported by 18.6% of patients overall. Patients with visual acuity worse than 0.3 logMAR made up 76% of those reporting CBS symptoms.<\/jats:p>\n                    <jats:p>Of the patients who experienced visual hallucinations, 59% reported that their visual hallucinations had no effect on them, while 29% reported a negative effect, with 12% not commenting; only 12% said that they require further support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CBS symptoms were reported by almost one in six patients in our IRD practice.<\/jats:p>\n                    <jats:p>Only a small proportion of patients included in this survey felt that they required additional support, but they did express that being informed early on of an explanation for their visual hallucinations was helpful.<\/jats:p>\n                    <jats:p>The limitations of our study are the small number of patients included in the survey, the lack of external validation of the questionnaire used, the risk of selection bias and the two different methods\/phases of data collection used.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjophth-2024-002104","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:30:13Z","timestamp":1751293813000},"page":"e002104","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Charles Bonnet syndrome in adults with inherited retinal disease: prevalence and patient perspectives"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-3933","authenticated-orcid":false,"given":"Thomas J M","family":"Weatherby","sequence":"first","affiliation":[{"name":"Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Boyle","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8203-0929","authenticated-orcid":false,"given":"Savita","family":"Madhusudhan","sequence":"additional","affiliation":[{"name":"St. Paul's Eye Department, Royal Liverpool University Hospital, Liverpool, UK"},{"name":"Department of Eye and Vision Sciences, University of Liverpool, Liverpool, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"2026010721203176000_10.1.e002104.1","unstructured":"ICD-11 for mortality and morbidity statistics. Available: https:\/\/icd.who.int\/browse\/2024-01\/mms\/en#920412840 [Accessed 27 Feb 2024]."},{"key":"2026010721203176000_10.1.e002104.2","doi-asserted-by":"publisher","DOI":"10.1097\/OPX.0000000000000959"},{"key":"2026010721203176000_10.1.e002104.3","doi-asserted-by":"publisher","DOI":"10.1097\/00041327-200406000-00003"},{"key":"2026010721203176000_10.1.e002104.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2006.10.007"},{"key":"2026010721203176000_10.1.e002104.5","first-page":"678","article-title":"The Charles Bonnet syndrome: visual hallucinations in the aged without mental deficiency","volume":"2","author":"de Morsier","year":"1967","journal-title":"Ann Med Psychol (Paris)"},{"key":"2026010721203176000_10.1.e002104.6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/aos.14287","article-title":"Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta-analysis","volume":"98","author":"Niazi","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"2026010721203176000_10.1.e002104.7","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ogla.2021.10.010","article-title":"Charles Bonnet Syndrome in Patients with Open-Angle Glaucoma: Prevalence and Correlation to Visual Field Loss","volume":"5","author":"Peters","year":"2022","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721203176000_10.1.e002104.8","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-319525"},{"key":"2026010721203176000_10.1.e002104.9","article-title":"Low awareness of the Charles Bonnet syndrome in patients attending a retinal clinic","volume":"61","author":"Singh","year":"2014","journal-title":"Dan Med J"},{"key":"2026010721203176000_10.1.e002104.10","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmy006"},{"key":"2026010721203176000_10.1.e002104.11","doi-asserted-by":"publisher","DOI":"10.3129\/I08-169"},{"key":"2026010721203176000_10.1.e002104.12","unstructured":"Glossary . Available: https:\/\/www.hra-decisiontools.org.uk\/research\/glossary.html#S [Accessed 23 Oct 2024]."},{"key":"2026010721203176000_10.1.e002104.13","unstructured":"Fitzgerald S . Retina UK sight loss survey 2022. Retina UK; 2022.46."},{"key":"2026010721203176000_10.1.e002104.14","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-304920"},{"key":"2026010721203176000_10.1.e002104.15","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/brain\/123.10.2055","article-title":"Visual hallucinatory syndromes and the anatomy of the visual brain","volume":"123 (Pt 10)","author":"Santhouse","year":"2000","journal-title":"Brain (Bacau)"},{"key":"2026010721203176000_10.1.e002104.16","unstructured":"GOV.UK . English indices of deprivation 2019: mapping resources. Available: https:\/\/www.gov.uk\/guidance\/english-indices-of-deprivation-2019-mapping-resources [Accessed 24 May 2024]."},{"key":"2026010721203176000_10.1.e002104.17","unstructured":"Rojas LC , Gurnani B . Charles bonnet syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. Available: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK585133\/"},{"key":"2026010721203176000_10.1.e002104.18","doi-asserted-by":"publisher","DOI":"10.1080\/09286580801939320"},{"key":"2026010721203176000_10.1.e002104.19","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.066027\/10.1136\/bjo.2005.068510"},{"key":"2026010721203176000_10.1.e002104.20","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.104604"},{"key":"2026010721203176000_10.1.e002104.21","doi-asserted-by":"crossref","DOI":"10.1007\/s11940-019-0582-1","article-title":"The Charles Bonnet Syndrome: a Systematic Review of Diagnostic Criteria","volume":"21","author":"Hamedani","year":"2019","journal-title":"Curr Treat Options Neurol"},{"key":"2026010721203176000_10.1.e002104.22","unstructured":"ICD-11 for mortality and morbidity statistics. Available: https:\/\/icd.who.int\/dev11\/l-m\/en#\/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1103667651 [Accessed 17 Mar 2025]."},{"key":"2026010721203176000_10.1.e002104.23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1442-9071.2008.01814.x","article-title":"Butterflies and black lacy patterns: the prevalence and characteristics of Charles Bonnet hallucinations in an Australian population","volume":"36","author":"Vukicevic","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"2026010721203176000_10.1.e002104.24","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ogla.2023.07.001","article-title":"Charles Bonnet Syndrome Adversely Affects Vision-Related Quality of Life in Patients with Glaucoma","volume":"7","author":"Randeblad","year":"2024","journal-title":"Ophthalmol Glaucoma"},{"key":"2026010721203176000_10.1.e002104.25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(96)90869-7","article-title":"Visual hallucinations in psychologically normal people: Charles Bonnet\u2019s syndrome","volume":"347","author":"Teunisse","year":"1996","journal-title":"The Lancet"},{"key":"2026010721203176000_10.1.e002104.26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192114600","article-title":"Loneliness and Social Support among the Middle-Aged and Elderly People with Visual Impairment","volume":"19","author":"Chu","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2026010721203176000_10.1.e002104.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000670","article-title":"Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19","volume":"6","author":"Jones","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"2026010721203176000_10.1.e002104.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(01)00833-9"},{"key":"2026010721203176000_10.1.e002104.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105140","article-title":"The impact of social deprivation on paranoia, hallucinations, mania and depression: the role of discrimination social support, stress and trust","volume":"9","author":"Wickham","year":"2014","journal-title":"PLoS One"},{"key":"2026010721203176000_10.1.e002104.30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1532-5415.1996.tb02937.x","article-title":"Charles Bonnet syndrome: an early marker for dementia?","volume":"44","author":"Pliskin","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"2026010721203176000_10.1.e002104.31","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3233\/JAD-210250","article-title":"Visual Impairment, Eye Diseases, and Dementia Risk: A Systematic Review and Meta-Analysis","volume":"83","author":"Ku\u017ama","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"2026010721203176000_10.1.e002104.32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.iae.0000243039.22011.5f","article-title":"Dementia with lewy bodies and charles bonnet syndrome","volume":"2","author":"Walker","year":"2008","journal-title":"Retin Cases Brief Rep"},{"key":"2026010721203176000_10.1.e002104.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000463","article-title":"Benefit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome","volume":"6","author":"Doeller","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"2026010721203176000_10.1.e002104.34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1444-0938.2004.tb03167.x","article-title":"Rehabilitation in Charles Bonnet syndrome: a review of treatment options","volume":"87","author":"Eperjesi","year":"2004","journal-title":"Clin Exp Optom"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2024-002104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:20:58Z","timestamp":1767849658000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2024-002104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,30]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/bmjophth-2024-002104"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2024-002104","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}